Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

Université de Montréal

$150,000.00

The neuromuscular function as a diagnostic tool and a therapeutic target in an ALS mouse model

EF 2016-17

Résumé
Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disease, leading to paralysis and death in 2 to 5 years after the diagnosis. In this disease, the specific connection between the motor nerve and the muscle is lost prematurely, leading to progressive difficulties in performing daily activities like moving, walking, eating and talking for example. Unfortunately, no cure is currently available. This specific connection between the motor neuron and the muscle is called the neuromuscular junction, and its destruction is one of the first events in the disease process, which highlights the importance of studying this variable. Alterations have been previously characterized at the neuromuscular junction (NMJ) in various animal models as well as in humans, even before symptoms onset, but several questions about NMJ and muscle function remain ill-defined. In addition, the role of glial cells during disease progression, a special type of cells that are present at the NMJ, also needs to be addressed. First, this project has the goal of understanding neuromuscular function in two different types of muscle, using a slow and progressive ALS mouse model. We also want to study muscle strength and contractile parameters of the muscles, in order to highlight early differences in the mutant mice that could lead to the development of a new diagnostic tool, if adapted for humans. Furthermore, a second aim of this study is to test potential drug therapies at the NMJ that could restore motor function and potentially lead to a cure if revealed efficient in humans. Finally, a third aim of this study is to gain insight on the role of the special glial cells at the NMJ during disease progression and their possible involvement in the pathologic process of ALS. These glial cells exert numerous important functions for the maintenance and health of the NMJ that could be impaired or perturbed in ALS, and could therefore represent a promising therapeutic target as well.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
362394
Name
Tremblay Elsa
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
The neuromuscular function as a diagnostic tool and a therapeutic target in an ALS mouse model
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Calcium Imaging; Electrophysiology; Electroporation; Glial Cells; Motor Unit; Muscle; Neuromuscular Junction; Perisynaptic Schwann Cells; Synaptic Transmission
Abstract
Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disease, leading to paralysis and death in 2 to 5 years after the diagnosis. In this disease, the specific connection between the motor nerve and the muscle is lost prematurely, leading to progressive difficulties in performing daily activities like moving, walking, eating and talking for example. Unfortunately, no cure is currently available. This specific connection between the motor neuron and the muscle is called the neuromuscular junction, and its destruction is one of the first events in the disease process, which highlights the importance of studying this variable. Alterations have been previously characterized at the neuromuscular junction (NMJ) in various animal models as well as in humans, even before symptoms onset, but several questions about NMJ and muscle function remain ill-defined. In addition, the role of glial cells during disease progression, a special type of cells that are present at the NMJ, also needs to be addressed. First, this project has the goal of understanding neuromuscular function in two different types of muscle, using a slow and progressive ALS mouse model. We also want to study muscle strength and contractile parameters of the muscles, in order to highlight early differences in the mutant mice that could lead to the development of a new diagnostic tool, if adapted for humans. Furthermore, a second aim of this study is to test potential drug therapies at the NMJ that could restore motor function and potentially lead to a cure if revealed efficient in humans. Finally, a third aim of this study is to gain insight on the role of the special glial cells at the NMJ during disease progression and their possible involvement in the pathologic process of ALS. These glial cells exert numerous important functions for the maintenance and health of the NMJ that could be impaired or perturbed in ALS, and could therefore represent a promising therapeutic target as well.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tremblay, Elsa
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~